Table 1 Reasons for noneligibility or nonevaluability for response

From: A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

Reasona

Arm A

Arm B

Arm C

Arm D

Presence or history of CNS metastasis

 

1

1

1

No measurable lesion

1

   

Patient not metastatic

 

1

  

Early discontinuation

 

3

1

8

Early death

 

1

  

Response not properly assessed

1

   

>1 line palliative chemotherapy

 

1

  

Total bilirubin >1.5 UNL

   

1

ASAT and ALAT >5 UNL

   

1

  1. aA patient may have more than one reason.
Back to article page